Ticker Details
Candel Therapeutics, Inc. Common Stock
IPO Date:	July 27, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$361.84M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.22 | 4.78%
Avg Daily Range (30 D):	$0.15 | 2.68%
Avg Daily Range (90 D):	$0.16 | 2.92%

Institutional Daily Volume
Avg Daily Volume:	.76M
Avg Daily Volume (30 D):	1.09M
Avg Daily Volume (90 D):	.85M

Trade Size
Avg Trade Size (Sh.):	153
Avg Trade Size (Sh.) (30 D):	99
Avg Trade Size (Sh.) (90 D):	104

Institutional Trades
Total Institutional Trades:	112
Avg Institutional Trade:	$1.42M
Avg Institutional Trade (30 D):	$.82M
Avg Institutional Trade (90 D):	$1.26M
Avg Institutional Trade Volume:	.2M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.05M
Avg Closing Trade (30 D):	$.96M
Avg Closing Trade (90 D):	$1.62M
Avg Closing Volume:	306.87K

News

Feb 20, 2026 @ 1:56 PM Stock Market Today: Dow Jones, S&P 500 Futures Sl... Source: Rishabh Mishra

Feb 20, 2026 @ 2:40 AM Candel Therapeutics Announces Pricing of Public Of... Source: Na

Feb 19, 2026 @ 9:05 PM Candel Therapeutics Announces Proposed $100 Millio... Source: Globe Newswire

Jan 23, 2026 @ 10:52 AM Oncolytic Virotherapy Market - Global Industry Siz... Source: Researchandmarkets.Com

Nov 4, 2025 @ 2:00 PM Candel Therapeutics Showcases Immunotherapy Leader... Source: Candel Therapeutics

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS		$-.21	$-.09
Diluted EPS		$-.21	$-.09
Revenue		$M	$M
Gross Profit
Net Income / Loss		$-11.27M	$-4.8M
Operating Income / Loss		$-13.21M	$-11.18M
Cost of Revenue
Net Cash Flow		$-13.72M	$8.52M
PE Ratio